Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
53 participants
INTERVENTIONAL
2006-07-31
2008-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single point cane
People with knee osteoarthritis underwent gait analysis with a cane
Single point cane
Participants with symptomatic knee osteoarthritis will undergo gait evaluation with and without a single point cane.
No cane
Patients with knee osteoarthritis undergo gait analysis without a cane
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Single point cane
Participants with symptomatic knee osteoarthritis will undergo gait evaluation with and without a single point cane.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to walk 30 feet without postural sway and able to stand unaided
* Knee pain on movement with a WOMAC pain subscale of \>35mm
* Documented osteoarthritis based on clinical and radiographic criteria
* Body Mass Index (BMI) \> 25.0 - 29.9
* Ability to understand verbal and written instructions
* Ability to give informed consent determined by assessment of cognitive status
Exclusion Criteria
* Severe obesity (weight \> 300lbs)
* Upper body weakness
* Injury or amputation of the lower extremity joints
* History of other types of arthritis
* Spine, foot, or hip pain of sufficient magnitude to interfere with the evaluation of the index joint.
* Isolated patellofemoral disease manifested by primarily anterior knee pain in the absence of tibiofemoral radiographic finding.
* History of significant collateral or anterior cruciate ligament or meniscal injury to the index joint requiring at least one week of non weight bearing (minor ligamentous injury prior to 6 months is not an exclusion).
* Poor health that would impair compliance or assessment such as shortness of breath with exertion
* Neurological disease including vestibular dysfunction, or impaired vision
* Patient has a history of any illness that, in the opinion of the investigator, might confound the results of the study or pose additional risk to the patient.
* Is unable to understand and complete the study questionnaires including visual analog scale (VAS) responses.
* Is unable to understand the study procedures.
* Investigator feels the patient is otherwise inappropriate for the study. The patient is participating in another clinical trial that would interfere with participation in this study
* Investigator feels the patient is otherwise inappropriate for the study.
* The patient is participating in another clinical trial that would interfere with participation in this study
45 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Meika Fang, MD
Role: PRINCIPAL_INVESTIGATOR
VA Greater Los Angeles Healthcare System, West LA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Greater Los Angeles Healthcare System, West LA
West Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Fang MA, Heiney C, Yentes JM, Harada ND, Masih S, Perell-Gerson KL. Effects of contralateral versus ipsilateral cane use on gait in people with knee osteoarthritis. PM R. 2015 Apr;7(4):400-6. doi: 10.1016/j.pmrj.2014.09.018. Epub 2014 Oct 8.
Harada N, Fong S, Heiney C, Yentes JM, Perell-Gerson KL, Fang MA. Evaluation of two cane instruments in older adults with knee osteoarthritis. J Rehabil Res Dev. 2014;51(2):275-83. doi: 10.1682/JRRD.2013.06.0140.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
F3873-R
Identifier Type: -
Identifier Source: org_study_id